Beta-L-2'-Deoxy Nucleosides for the Treatment of Hepatitis B

Details for Australian Patent Application No. 2004201286 (hide)

Owner Idenix (Cayman) Limited Centre National de la Recherche Scientifique L'Universite Montpellier II

Inventors Imbach, Jean-Louis; Gosselin, Gilles; Bryant, Martin L

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-B-2004201286

Parent 54757

Filing date 26 March 2004

Wipo publication date 6 May 2004

Acceptance publication date 21 June 2007

International Classifications

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

22 April 2004 Complete Application Filed

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2004201286

21 June 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor names to read Imbach, JeanLouis; Gosselin, Gilles and Bryant, Martin L

21 June 2007 Application Accepted

  Published as AU-B-2004201286

18 October 2007 Standard Patent Sealed

12 January 2012 Assignment Registered

  L'Universite Montpellier II; Centre National de la Recherche Scientifique (CNRS); Idenix (Cayman) Limited The patent has been assigned to L'Universite Montpellier II; Centre National de la Recherche Scientifique (CNRS); Idenix Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201287-Soluble CTLA4 mutant molecules and uses thereof

2004201285-Tissue-specific and target RNA-specific ribozymes